Is Anthem Biosciences Ltd debt-free?

Yes, Anthem Biosciences Ltd is debt-free with a debt-to-equity ratio of 0.05.

Home

Anthem Biosciences Ltd

Anthem Biosciences Ltd Financials

Anthem Biosciences Ltd Financial Statement

Anthem Biosciences Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

No Data Available

Anthem Biosciences Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
Total Revenue Annual	1,840.65	1,417.54	1,056.92
Operating Expenses Annual	1,151.64	912.65	627.87
Operating Profit Annual	798.45	575.41	568.23
Interest Annual	9.09	9.14	6.75
Depreciation	77.94	81.49	63.70
Net Profit Annual	506.19	374.78	385.67
Tax Annual	205.24	109.99	112.11

Particulars	Mar 2025
Total Revenue Annual	1,840.65
Operating Expenses Annual	1,151.64
Operating Profit Annual	798.45
Interest Annual	9.09
Depreciation	77.94
Net Profit Annual	506.19
Tax Annual	205.24

Anthem Biosciences Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
Cash Flow at the Beginning	183.85	342.79	348.87
Cash Flow from Operations	439.84	164.41	318.98
Cash Flow from Investing	-246.31	-191.76	-377.91
Cash Flow from Financing	-66.42	-131.59	52.85
Cash Flow at the End	310.95	183.85	342.79

Particulars	Mar 2025
Cash Flow at the Beginning	183.85
Cash Flow from Operations	439.84
Cash Flow from Investing	-246.31
Cash Flow from Financing	-66.42
Cash Flow at the End	310.95

Anthem Biosciences Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
PBDIT Margin (%)	43.39	40.60	48.86
PBIT Margin (%)	39.16	34.85	42.83
PBT Margin (%)	34.95	31.09	37.91
Net PROFIT Margin (%)	27.50	26.44	36.49
Return On Networth / Equity (%)	22.98	20.40	22.27
Return On Networth /Employed (%)	30.46	24.74	27.47
Return On Assets (%)	21.45	18.77	23.35
Total Debt / Equity (X)	0.06	0.08	0.05
Asset Turnover Ratio (%)	0.78	0.71	0.64

Particulars	Mar 2025
PBDIT Margin (%)	43.39
PBIT Margin (%)	39.16
PBT Margin (%)	34.95
Net PROFIT Margin (%)	27.50
Return On Networth / Equity (%)	22.98
Return On Networth /Employed (%)	30.46
Return On Assets (%)	21.45
Total Debt / Equity (X)	0.06
Asset Turnover Ratio (%)	0.78

Anthem Biosciences Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
Fixed Assets Annual	624.06	477.69	448.89
Total Current Assets Annual	1,664.07	1,445.49	1,319.62
Non Current Assets Annual	1,171.49	878.74	673.39
Total Shareholders Funds Annual	2,473.21	1,933.07	1,741.62
Total Assets Annual	2,835.56	2,324.23	1,993.02

Particulars	Mar 2025
Fixed Assets Annual	624.06
Total Current Assets Annual	1,664.07
Non Current Assets Annual	1,171.49
Total Shareholders Funds Annual	2,473.21
Total Assets Annual	2,835.56

Anthem Biosciences Ltd Earning Calls

No Data Availabe

Dividend Pages

PE Ratio

FAQS on Anthem Biosciences Ltd Financials

As of Aug 11, 2025, Anthem Biosciences Ltd has a market capitalization of - Cr. Value Research classifies it as a Micro-Cap company.

Yes, Anthem Biosciences Ltd is with a debt-to-equity ratio of 0.05.

In FY 2024 , Anthem Biosciences Ltd recorded a total revenue of approximately 1,840.65 Cr marking a significant milestone in the company's financial performance.

Anthem Biosciences Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately NaN% and 0.3% annually, respectively..

Anthem Biosciences Ltd's current PE ratio is .

Anthem Biosciences Ltd's ROCE averaged 25.5% from the FY ending March 2024 to 2025, with a median of 25.5%. It peaked at 27.7% in March 2025, reflecting strong capital efficiency over the period..

Anthem Biosciences Ltd's latest EBIT is Rs. 720.51 Cr, surpassing the average EBIT of Rs. 607.21 Cr over the 5 years..